National Drug Threat Survey

Forms and Documents

Document	Type	Status	Availability
FINAL OMB NDTS 2017 Supporting Statement PART B.doc	Supporting Statement B	Uploaded 2016-08-25	Available
FINAL OMB NDTS 2017 Supporting Statement PART A.doc	Supporting Statement A	Uploaded 2016-08-25	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
204402	NDTS (PDF Version)	Other-null	Modified

ICR Details

OMB Control No: 1117-0052	ICR Reference No: 201608-1117-002
Status: Historical Inactive	Previous ICR Reference No: 201305-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: National Drug Threat Survey
Type of Information Collection: Reinstatement with change of a previously approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Disapproved	Conclusion Date: 07/24/2017
	Date Received in OIRA: 11/28/2016
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date		36 Months From Approved
Responses	0	0	0
Time Burden (Hours)	0	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: The DEA is congressionally mandated to prepare high priority strategic drug intelligence in order to provide lawmakers with the most current information on availability, demand, production, cultivation, transportation, and distribution, as well as the effects of drugs on the abusers and society.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 59656	08/30/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 76964	11/04/2016
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
NDTS (PDF Version)

---

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: 5. DEA intends to use NDTS response data for several purposes. DEA analysts will use NDTS data to corroborate drug intelligence data obtained from other sources that include: federal drug investigations initiated and conducted through the Organized Crime Drug Enforcement (OCDETF) Task Forces program administered by the Department of Justice; federal drug seizure data collected through the National Seizure System maintained by the DEA El Paso Intelligence Center (EPIC); national level drug demand and usage studies conducted by the Department of Health and Human Services that include the National Survey on Drug Use and Health (NSDUH), the Monitoring the Future (MTF) study, the Centers for Disease Control (CDC) reports on drug overdose deaths, and the Treatment Episode Data Set (TEDS) for admissions to drug treatment agencies; and reports and summaries from intelligence reporting from other federal state and local law enforcement agencies, drug task forces, and investigators’ associations.

---

Annual Cost to Federal Government: $72,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/28/2016

---